Inventor · disambiguated record
Theresa O'Keefe
Also filed as: O'KEEFE THERESA · O'KEEFE THERESA L
25 granted patents·24 pending applications·442 citations·filing 2000–2025
96Inventor score
Files withMILLENNIUM PHARM INC15ONEIGHTYºC TECH CORPORATION5CRITICAL THERAPEUTICS INC4O'KEEFE THERESA4O'KEEFE THERESA L3
Top patents by PatentIndex Score
49 records- 0198US6696550B2Humanized anti-CCR2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2001·Granted Feb 24, 2004·135 cites·74 claims
- 0297US6727349B1Recombinant anti-CCR2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2000·Granted Apr 27, 2004·81 cites·62 claims
- 0396US7053202B2Immunoglobulin DNA cassette molecules, monobody constructs, methods of production, and methods of use thereforMILLENNIUM PHARM INC·Filed 2002·Granted May 30, 2006·62 cites·37 claims
- 0493US7288250B2Monoclonal antibodies against HMGB1CRITICAL THERAPEUTICS INC·Filed 2004·Granted Oct 30, 2007·44 cites·8 claims
- 0592US7632500B2Monoclonal antibodies against HMGB1CORNERSTONE THERAPEUTICS INC·Filed 2007·Granted Dec 15, 2009·17 cites·7 claims
- 0692US7470521B2RAGE protein derivativesCRITICAL THERAPEUTICS INC·Filed 2005·Granted Dec 30, 2008·38 cites·24 claims
- 0790US7442775B2Humanized anti-CCR2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2004·Granted Oct 28, 2008·15 cites·38 claims
- 0889US7566450B2Humanized anti-CCR2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2007·Granted Jul 28, 2009·6 cites·18 claims
- 0987US7473421B2Humanized anti-CCR2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2004·Granted Jan 6, 2009·11 cites·23 claims
- 1086US8785600B2Anti-GCC antibody molecules and related compositions and methodsNAM SAMUEL S·Filed 2010·Granted Jul 22, 2014·10 cites·16 claims
- 1185US8227211B2Humanized anti-CCR2 antibodies and methods of use thereforLAROSA GREGORY J·Filed 2008·Granted Jul 24, 2012·5 cites·23 claims
- 1279US8753828B2Humanized anti-CCR2 antibodies and methods of use thereforO'KEEFE THERESA·Filed 2010·Granted Jun 17, 2014·4 cites·9 claims
- 1379US8129130B2High affinity antibodies against HMGB1 and methods of use thereofWU HERREN·Filed 2011·Granted Mar 6, 2012·5 cites·4 claims
- 1475US8926971B2Humanized anti-CCR2 antibodies and methods of use thereforLAROSA GREGORY J·Filed 2012·Granted Jan 6, 2015·1 cites·23 claims
- 1572US9440269B2System and method for disposal of mutagen wastePHARMA-CYCLE LLC·Filed 2014·Granted Sep 13, 2016·3 cites·24 claims
- 1672US9242282B2System and method for disposal of mutagen wasteMULLOWNEY JAMES T·Filed 2012·Granted Jan 26, 2016·3 cites·27 claims
- 1770US9273146B1Anti-GCC antibody molecules and methods for use of sameMILLENNIUM PHARM INC·Filed 2015·Granted Mar 1, 2016·1 cites·12 claims
- 1869US10941211B2Anti-GCC antibody molecules and related compositions and methodsMILLENNIUM PHARM INC·Filed 2018·Granted Mar 9, 2021·0 cites·12 claims
- 1969US2015086546A1Humanized anti-ccr2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2014·Application pending·0 cites
- 2067US2008268536A1Humanized Anti-CCR2 Antibodies and Methods of Use ThereforMILLENNIUM PHARM INC·Filed 2007·Application pending·0 cites
- 2167US2008241923A1Humanized Anti-CCR2 Antibodies and Methods of Use ThereforMILLENNIUM PHARM INC·Filed 2007·Application pending·0 cites
- 2266US10457973B2Method for rapidly determining effective sterilization, deimmunization, and/or disinfectionONEIGHTY C TECH CORPORATION·Filed 2019·Granted Oct 29, 2019·0 cites·15 claims
- 2365US9353184B2Humanized anti-CCR2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2014·Granted May 31, 2016·0 cites·8 claims
- 2465US2009012269A1Humanized anti-ccr2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2008·Application pending·0 cites
- 2565US2020263226A1Method for Rapidly Determining Sterilization, Deimmunization, and/or DisinfectionONEIGHTY°C TECH CORPORATION·Filed 2019·Application pending·0 cites
- 2662US9000129B2Anti-GCC antibody molecules and methods for use of sameFRANK HELEN ALISON·Filed 2013·Granted Apr 7, 2015·1 cites·18 claims
- 2762US2009169541A1Humanized Anti-CCR2 Antibodies and Methods of Use ThereforMILLENNIUM PHARM INC·Filed 2007·Application pending·0 cites
- 2860US10246731B2Method for rapidly determining effective sterilization , deimmunization, and/or disinfectionONEIGHTY C TECH CORPORATION·Filed 2017·Granted Apr 2, 2019·0 cites·15 claims
- 2960US9057063B2Genetically modified biological cellsO'KEEFE THERESA·Filed 2008·Granted Jun 16, 2015·0 cites·11 claims
- 3059US2021371881A1Devices and methods for transfectionTRANSCYTOS LLC·Filed 2021·Application pending·0 cites
- 3158US2004141948A1Use of HMGB fragments as anti-inflammatory agentsCRITICAL THERAPEUTICS INC·Filed 2003·Application pending·0 cites
- 3257US2008124320A1Use of HMGB fragments as anti-inflammatory agentsO'KEEFE THERESA L·Filed 2007·Application pending·0 cites
- 3357US2004151721A1Humanized anti-CCR2 antibodies and methods of use thereforFiled 2003·Application pending·0 cites
- 3456US2025327090A1Devices and Methods for TransfectionTRANSCYTOS LLC·Filed 2025·Application pending·0 cites
- 3556US2014322233A1Anti-gcc antibody molecules and related compositions and methodsNAM SAMUEL S·Filed 2014·Application pending·0 cites
- 3656US2009148453A1Monoclonal antibodies against HMGB1NEWMAN WALTER·Filed 2007·Application pending·0 cites
- 3754US10471483B2System and method for disposal of mutagen wastePHARMA CYCLE LLC·Filed 2016·Granted Nov 12, 2019·0 cites·12 claims
- 3854US2009202542A1Rage protein derivativesCRITICAL THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 3950US8846047B2Monoclonal antibodies against HMGB1NEWMAN WALTER·Filed 2010·Granted Sep 30, 2014·0 cites·16 claims
- 4050US2016130344A1Anti-gcc antibody molecules and methods for use of sameMILLENNIUM PHARM INC·Filed 2016·Application pending·0 cites
- 4150US2006147445A1Immunoglobulin DNA cassette molecules, monobody constructs, methods of production, and methods of use thereforO'KEEFE THERESA·Filed 2005·Application pending·0 cites
- 4249US2003144193A1TANGO 197 and TANGO 216 compositions and methodsFiled 2002·Application pending·0 cites
- 4347US2003134786A1TANGO 197 and TANGO 216 compositions and methodsFiled 2001·Application pending·0 cites
- 4446US2002147312A1Hybrid antibodies and uses thereofFiled 2002·Application pending·0 cites
- 4545US2007122404A1Humanized immunoglobulin reactive with alpha4beta7 integrinO'KEEFE THERESA L·Filed 2006·Application pending·0 cites
- 4645US2015353941A1Genetically Modified Biological CellsO'KEEFE THERESA·Filed 2015·Application pending·0 cites
- 4743US2006040354A1Novel polyadenylation signal for use in expression vectorsO'KEEFE THERESA L·Filed 2005·Application pending·0 cites
- 4841US2018154030A1System and Method For Sterilizing and/or Deimmunizing an ObjectONEIGHTY C TECH CORPORATION·Filed 2017·Application pending·0 cites
- 4939US2019328912A1System and method for sterilizing and/or deimmunizing an objectONEIGHTYºC TECH CORPORATION·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →